- $2.24bn
- $1.79bn
- $4.32bn
- 30
- 51
- 20
- 25
Annual balance sheet for Agilon Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 124 | 107 | 1,040 | 909 | 488 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 93.3 | 145 | 293 | 498 | 942 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 246 | 294 | 1,367 | 1,451 | 1,480 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 18.8 | 16 | 20.9 | 33.1 | 41 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 403 | 446 | 1,586 | 1,697 | 1,741 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 200 | 267 | 357 | 535 | 977 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 354 | 422 | 494 | 656 | 1,079 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 49 | 24.8 | 1,092 | 1,041 | 662 |
| Total Liabilities & Shareholders' Equity | 403 | 446 | 1,586 | 1,697 | 1,741 |
| Total Common Shares Outstanding |